Navigation Links
AEterna Zentaris' Partner, Spectrum, Discloses Detailed Phase 2,Data for Ozarelix, in BPH at Annual AUA Meeting

aseline International Prostate Symptom Score (IPSS) and uroflow values. Afterwards, 144 patients meeting the inclusion criteria were randomly allocated to one of five treatment groups with the following dosage regimens:

    - Placebo;

    - Ozarelix 5 mg on Day 1 + 5 mg on Day 15;

    - Ozarelix 10 mg on Day 1 +10 mg on Day 15;

    - Ozarelix 15 mg on Day 1 + 15 mg on Day 15; or

    - Ozarelix 20 mg on Day 1 only.

Patients were followed for 28 weeks. The primary efficacy endpoint was change in IPSS at week 12 compared to baseline. Secondary efficacy endpoints included changes in IPSS, Quality of Life (QoL), patients with >= 30% and >= 40% improvement in IPSS, uroflow values (Qmax), postvoid residual (PVR) urine volume and prostate volume. Safety analysis included changes in sexual function (IIEF-5), treatment of emergent adverse events (AEs), lab values (including testosterone (T), PSA) and vital signs. Mean age was 69.1 (range 52 - 85), IPSS 19.8, Qmax 9.7 mL/sec. and prostate size (cm(3)) 41.6 at baseline.

Results

The effects developed rapidly, with noticeable activity at four weeks from starting treatment, were maximal at 12-16 weeks, and persisted for the 6 month observation period. At week 12, all ozarelix-treated groups showed improvement with the greatest improvement in the 15 mg + 15 mg group. Change from baseline in IPSS was 8.6 (p<0.001); change from baseline in urine flow was 4.7 (p=0.002); T levels declined transiently and returned to baseline in most patients by 4 weeks and all patients by 6 weeks following dosing. Based on IIEF, there was no effect seen on erectile function.

Serious adverse events were reported in 4 patients on ozarelix (myocardial infarction, pneumonitis, hypotension, renal colic), but were not considered treatment related. No systemic allergic reactions were seen and the injections were well tolerated.

    Conclusions


    - Ozarelix was well tolerated;

    - Statistically sig
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. AEterna Zentaris Partner Keryx Presents Phase 1 and Phase 2 Results for Anti-Cancer Compound Perifosine at ASCO Meeting
2. AEterna Zentaris Discloses In Vivo Data for its GHRH Antagonist JMR-132 at the AACR Annual Meeting in Los Angeles
3. AEterna Zentaris Discloses First In Vitro Data for its PI3K Inhibitors at the AACR Annual Meeting in Los Angeles
4. AEterna Zentaris To Present First In Vitro Data for PI3K Inhibitors and In Vivo Results for a GHRH Antagonist at the AACR Annual Meeting in Los Angeles
5. AEterna Zentaris Reports Positive Results with Cetrorelix in BPH for Japanese Phase 2a Trial
6. terna Zentaris Discloses First In Vitro Data for its PI3K Inhibitors at the AACR Annual Meeting in Los Angeles
7. Genzyme and Bayer HealthCare Announce Detailed Interim Two-Year Alemtuzumab in Multiple Sclerosis Data Presented at AAN
8. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
9. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
10. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
11. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis

Post Your Comments:
(Date:11/27/2009).../ -- At the upcoming Radiological Society of North...yal Philips Electronics ( PHG, AEX: PHI) will demo...rmatics solutions designed to directly address the...ivering meaningful imaging innovations that reflec...y upgradability. This focus will enable Philips t...
(Date:11/25/2009)...PRNewswire/ -- Praxis Electronic Medical Records r...my of Family Physicians, (AAFP) Family Practice Ma...or improving medical quality, health maintenance, ...Stimulus legislation. Praxis also ranked #1 among ... in determining their salary. Finally, Praxis also...
(Date:11/25/2009)...ewswire-FirstCall/ -- Heska Corporation ( HSKA); (...tic and specialty products to the veterinary indus...tics Corporation for the supply of blood gas produ...market. ,, (Logo: http://www.newscom.com/c...Roche share the same passion for innovating in the...
Breaking Medicine Technology:Philips Helps Hospitals Strike Balance Between Innovation and Value 2Philips Helps Hospitals Strike Balance Between Innovation and Value 3Philips Helps Hospitals Strike Balance Between Innovation and Value 4Praxis EMR Wins Top Rankings in 2009 AAFP EHR User Satisfaction Survey 2Heska Announces Supply Agreement With Roche Diagnostics 2Heska Announces Supply Agreement With Roche Diagnostics 3Heroes of Chemistry for saving teeth clean water new high blood pressure drug 54594 1Heroes of Chemistry for saving teeth clean water new high blood pressure drug 54594 2Heroes of Chemistry for saving teeth clean water new high blood pressure drug 54594 3Heroes of Chemistry for saving teeth clean water new high blood pressure drug 54594 4Newly found DNA catalysts cleave DNA with water molecule 9589 1Newly found DNA catalysts cleave DNA with water molecule 9589 2Inherited risk factors increase odds of developing childhood acute lymphoblastic leukemia 9587 1Inherited risk factors increase odds of developing childhood acute lymphoblastic leukemia 9587 2Inherited risk factors increase odds of developing childhood acute lymphoblastic leukemia 9587 3
...W ROCHELLE, N.Y., May 13 Gene therapy to replace ...tive disease that is fatal by,age 8-12 years, was ...decline in treated children, according to a paper ...sue (Vol. 19 No. 5) of Human Gene Therapy, a,peer-...c. The paper is,available free online at http://w...
...pecific biomarkers for molecular tumor grade and e...n of individual patient outcome-, SAN DIEGO, May ... of an article describing the discovery, developme...iara MGI(SM) (Molecular Grade,Index), that improve...the,prediction of distant disease recurrence. The ...
Other Medicine Technology:Gene Therapy Slows Progression of Fatal Neurodegenerative Disease in Children 2AviaraDx Confirms That Combination of Two Molecular Biomarkers Improves Prediction of Disease Recurrence in Early Stage Breast Cancer Patients 2AviaraDx Confirms That Combination of Two Molecular Biomarkers Improves Prediction of Disease Recurrence in Early Stage Breast Cancer Patients 3AviaraDx Confirms That Combination of Two Molecular Biomarkers Improves Prediction of Disease Recurrence in Early Stage Breast Cancer Patients 4
(Date:11/28/2009)... recognize signs of depression , , SATUR... the holiday season can trigger melancholy as they... issues or worry about money problems, according t...ercome the seasonal blues, the AGS Foundation for ...et out and socialize or invite family and friends ...
(Date:11/27/2009)...swire-FirstCall/ -- The Gymboree Corporation (Nasd... will present at the NASDAQ OMX 23rd Investor Prog...ondon, England, on Wednesday, December 2, 2009, at...st of The Gymboree Corporation,s presentation over...click on "Our Company" at the bottom of the page, ...
(Date:11/27/2009)...hicles may reduce future disease burden, researche...ws) -- Encouraging city dwellers to walk and bicyc...public health benefits than increased used of low-..., The study compared the projected health effects...rios for London, England, and Delhi, India: busin...
(Date:11/27/2009)...ufacturers who use medical load cells at the heart...by bringing in technology partner Flintec early in...ive medical manufacturers are calling in Flintec l...jects, ensuring that progress will not be constrai...tdated technology. , (PRW...
(Date:11/26/2009)...molybdate (TM) has been shown in studies to be eff...se caused by an overload of copper, and certain me... however, is known about how the drug works at the...ern University researchers now has provided an inv...M bound to copper-loaded metallochaperones. The dr...
Breaking Medicine News(10 mins):Health News:Seniors May Need Help Overcoming Holiday Blues 2Health News:More Foot Power, Less Car Pollution Best for Health 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4Health News:Research sheds light on workings of anti-cancer drug 2Health News:Research sheds light on workings of anti-cancer drug 3
...GTON In a new collaboration, the Marian Koshland ... is licensing several components of its global war...ce Centre Singapore. The partnership marks an expa...d the world. , "We are very excited to join force...
... Ill., May 15 New research appearing in the,May i...sociation for,Psychological Science, suggests that...,s basic cognitive functioning and thus, their abi...alinsky of,the Kellogg School of Management at Nor...
... Energy Crisis One Sip At a Time, People across A... With,hectic, busy lifestyles, many Americans need...mmons invites New Yorkers to help solve their "ene...by to meet,the fitness guru and fuel-up on natural...
... only international volunteer service organization...and long-term needs, OAK BROOK, Ill., May 15 Tod...ounced that it is mobilizing US$1.5,million to aid...he powerful, massive,earthquake that struck Sichua...
... higher risk than Hispanics, but genetics determin...lthDay News) -- Genetic differences may explain wh...n Hispanic men, information which may help doctors... from south Texas and looked for mutations from th...
...e daily use of doctor-recommended proton pump inhi...isease (GERD) symptoms, nearly 40 percent of patie...ugh, which is a return of GERD symptoms, such as a...o a survey recently conducted by the American Gast...
Other Medicine News:Health News:Marian Koshland Science Museum forms partnership with Science Center Singapore 2Health News:Having Less Power Impairs the Mind and Ability to Get Ahead, Study Shows 2Health News:MultiVu Video Feed: Richard Simmons and Ocean Spray Team-Up to Solve 2Health News:Lions Mobilize $1.5 Million for China Earthquake Relief 2Health News:Lions Mobilize $1.5 Million for China Earthquake Relief 3Health News:Lions Mobilize $1.5 Million for China Earthquake Relief 4Health News:Genes Play Part in Prostate Cancer Among Races 2Health News:Nearly 40 percent of GERD patients taking PPIs experience recurring symptoms 2Health News:Nearly 40 percent of GERD patients taking PPIs experience recurring symptoms 3
Humeral Stabilizing System (HSS)
Humerus Fracture Brace
Functional Arm Brace
Extended Length Humeral Splint
Medicine Products: